Concepedia

Kewen Hu

KH

Statistics

Publications

13

Citations

1.2K

H-Index

13

Active since

2016

Affiliations

East China Normal University(Current)

Fudan University Shanghai Cancer Center

Southern Medical University

The University of Texas MD Anderson Cancer Center

Shanghai Changning Maternity and Infant Health Hospital

Kewen Hu is an author at East China Normal University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2016–2025

13

Publications

13

Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma

Kewen Hu, Kun Li, Jing Lv et al. · Journal of Clinical Investigation · 2019 · 397 citations · Full text

, , +17

Autophagy inhibition enabled efficient photothermal therapy at a mild temperature

Zhengjie Zhou, Yan Yang, Kewen Hu et al. · Biomaterials · 2017 · 181 citations

, , +13

CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse

Yuting Guan, Yanlin Ma, Qi Li et al. · EMBO Molecular Medicine · 2016 · 170 citations · Full text

, , +15

Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK

Jieqiong Wang, Kewen Hu, Jiawei Guo et al. · Nature Communications · 2016 · 99 citations · Full text

, , +17

Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression

Qian Lin, Na Li, Xiaochen Lu et al. · Nature Metabolism · 2023 · 76 citations · Full text

, , +9

1–5 of 13